Westminster Pharmaceuticals Llc

FDA Regulatory Profile

Summary

Total Recalls
10 (5 Class I)
510(k) Clearances
0
Inspections
1
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0581-2025Class IIMetoprolol Tartrate Tablets, USP, 50 mg, 1000 Tablets, Rx Only, Manufactured by: Renata PLC (GeneralAugust 6, 2025
D-0582-2025Class IIMetoprolol Tartrate Tablets, USP, 100 mg, 1000 Tablets, Rx Only, Manufactured by: Renata PLC (GeneraAugust 6, 2025
D-0302-2019Class IIWestminster Irbesartan Tablets, USP 300 mg Rx Only Manufactured by: ScieGen Pharmaceuticals, Inc. HaOctober 29, 2018
D-0301-2019Class IIWestminster Irbesartan Tablets, USP 150 mg Rx Only Manufactured by: ScieGen Pharmaceuticals, Inc. HaOctober 29, 2018
D-0300-2019Class IIWestminster Irbesartan Tablets, USP 75 mg Rx Only Manufactured by: ScieGen Pharmaceuticals, Inc. HauOctober 29, 2018
D-1181-2018Class ILevothyroxine and Liothyronine (Thyroid Tablets, USP), 1/4 grain (15 mg), 100-count bottles, Rx OnlyAugust 3, 2018
D-1178-2018Class ILevothyroxine and Liothyronine (Thyroid Tablets, USP), 1 grain (60 mg), 100-count bottles, Rx Only, August 3, 2018
D-1179-2018Class ILevothyroxine and Liothyronine (Thyroid Tablets, USP), 1 & 1/2 grain (90 mg), 100-count bottles, Rx August 3, 2018
D-1182-2018Class ILevothyroxine and Liothyronine (Thyroid Tablets, USP), 2 grain (120 mg), 100-count bottles, Rx Only,August 3, 2018
D-1180-2018Class ILevothyroxine and Liothyronine (Thyroid Tablets, USP), 1/2 grain (30 mg), 100-count bottles, Rx OnlyAugust 3, 2018